{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:08:28Z","timestamp":1779253708337,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571170"],"award-info":[{"award-number":["32571170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371030"],"award-info":[{"award-number":["32371030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuropharm.2026.110890","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:03:20Z","timestamp":1771891400000},"page":"110890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibiting AP2M1-mediated GluA2 endocytosis by G2CT peptide ameliorates synaptic and memory deficits in Alzheimer's Disease"],"prefix":"10.1016","volume":"290","author":[{"given":"Mengtong","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yepeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110890_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1483","article-title":"Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting","volume":"363","author":"Awasthi","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110890_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaneurol.2024.3733","article-title":"Deferiprone in alzheimer disease: a randomized clinical trial","volume":"82","author":"Ayton","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2026.110890_bib3","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.neuropharm.2026.110890_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41419-018-1172-y","article-title":"Glucocorticoid-mediated ER-mitochondria contacts reduce AMPA receptor and mitochondria trafficking into cell terminus via microtubule destabilization","volume":"9","author":"Choi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.110890_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrn2867","article-title":"Long-term depression in the CNS","volume":"11","author":"Collingridge","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110890_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1172\/JCI77888","article-title":"Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis","volume":"125","author":"Dong","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.110890_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14543","article-title":"Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's-related phenotypes","volume":"21","author":"Feng","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110890_bib8","doi-asserted-by":"crossref","first-page":"16697","DOI":"10.1073\/pnas.1008200107","article-title":"Hippocampal long-term depression is required for the consolidation of spatial memory","volume":"107","author":"Ge","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2026.110890_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuron.2008.02.022","article-title":"Expression of long-term depression underlies visual recognition memory","volume":"58","author":"Griffiths","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110890_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1516190","article-title":"Parishin A ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer's disease","volume":"17","author":"Guo","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110890_bib11","article-title":"Peptide drug: design and clinical applications","volume":"2020","author":"Han","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.neuropharm.2026.110890_bib12","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0141","article-title":"GluA2-dependent AMPA receptor endocytosis and the decay of early and late long-term potentiation: possible mechanisms for forgetting of short- and long-term memories","volume":"369","author":"Hardt","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110890_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70194","article-title":"Inhibition of hippocampal mossy fiber plasticity and episodic memory by human A\u03b2 oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice","volume":"21","author":"Jin","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110890_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-022-01002-x","article-title":"Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"14","author":"Kivis\u00e4kk","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2026.110890_bib15","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.neuron.2025.06.002","article-title":"Dynamic redistribution of AMPA receptors toward memory-related neuronal ensembles in mice barrel cortex during sensory learning","volume":"113","author":"Li","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110890_bib16","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41380-022-01579-7","article-title":"Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory","volume":"27","author":"Li","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110890_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112233","article-title":"Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke","volume":"42","author":"Lu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.110890_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.apsb.2023.10.015","article-title":"miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease","volume":"14","author":"Luo","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuropharm.2026.110890_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET","volume":"16","author":"Mecca","year":"2020","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110890_bib20","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261281","article-title":"A\u03b2 peptide enhances GluA1 internalization via lipid rafts in Alzheimer's-related hippocampal LTP dysfunction","volume":"137","author":"Midorikawa","year":"2024","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2026.110890_bib21","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1523\/JNEUROSCI.3333-15.2016","article-title":"Blocking synaptic removal of GluA2-Containing AMPA receptors prevents the natural forgetting of long-term memories","volume":"36","author":"Migues","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110890_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70403","article-title":"Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer's disease","volume":"21","author":"Nilsson","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110890_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12959","article-title":"Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: implications for Alzheimer's disease","volume":"54","author":"Qu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.neuropharm.2026.110890_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40478-025-02096-8","article-title":"Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer's disease mouse model","volume":"13","author":"Ramonet","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2026.110890_bib25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.05.003","article-title":"AMPA receptor signaling through BRAG2 and Arf6 critical for long-term synaptic depression","volume":"66","author":"Scholz","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110890_bib26","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/s41467-025-60746-w","article-title":"Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis","volume":"16","author":"Su","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110890_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12974-018-1082-z","article-title":"Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: underlying mechanisms","volume":"15","author":"Taoro-Gonzalez","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110890_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184656","article-title":"APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer's disease","volume":"135","author":"Tian","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.110890_bib29","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301173RRR","article-title":"Hypoxia-sensing VGLL4 promotes LDHA-driven lactate production to ameliorate neuronal dysfunction in a cellular model relevant to Alzheimer's disease","volume":"37","author":"Tian","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.110890_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.conb.2020.01.011","article-title":"Pathogenic A\u03b2 generation in familial Alzheimer's disease: novel mechanistic insights and therapeutic implications","volume":"61","author":"Trambauer","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110890_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14490","article-title":"KIF9 ameliorates neuropathology and cognitive dysfunction by promoting macroautophagy in a mouse model of Alzheimer's disease","volume":"24","author":"Wang","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2026.110890_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13024-023-00632-5","article-title":"The Q\/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer's disease","volume":"18","author":"Wright","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110890_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2024.10.018","article-title":"Meningeal neutrophil immune signaling influences behavioral adaptation following threat","volume":"113","author":"Wu","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110890_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt7981","article-title":"Disruption of BAG3-mediated BACE1 stabilization alleviates neuropathology and memory deficits in a mouse model of Alzheimer's disease","volume":"11","author":"Xia","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.110890_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70084","article-title":"Amyloid precursor protein and presenilin-1 knock-in immunodeficient mice exhibit intraneuronal A\u03b2 pathology, microgliosis, and extensive neuronal loss","volume":"21","author":"Yeapuri","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110890_bib36","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s12276-025-01455-8","article-title":"ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer's disease","volume":"57","author":"Yi","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.110890_bib37","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1073\/pnas.0901305106","article-title":"Essential role for a long-term depression mechanism in ocular dominance plasticity","volume":"106","author":"Yoon","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2026.110890_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-025-03528-x","article-title":"Circulatory extracellular vesicles transport complement C1q for promoting neuronal amyloid-\u03b2 production in Alzheimer's disease","volume":"22","author":"Yu","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110890_bib39","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.4103\/NRR.NRR-D-24-00751","article-title":"Targeting Epac2 and GluA3-containing AMPARs: a novel therapeutic strategy for Alzheimer's disease","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.110890_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/JAD-220009","article-title":"Cattle encephalon glycoside and ignotin ameliorate palmitoylation of PSD-95 and enhance expression of synaptic proteins in the frontal cortex of a APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"88","author":"Zhang","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2026.110890_bib41","article-title":"Insights into biomarkers of Alzheimer's disease: from core markers to emerging directions","author":"Zhu","year":"2025","journal-title":"Aging Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:36:15Z","timestamp":1779251775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S0028390826000638"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110890","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting AP2M1-mediated GluA2 endocytosis by G2CT peptide ameliorates synaptic and memory deficits in Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110890"}}